ATE549025T1 - Emailleformulierung mit amelogenin - Google Patents

Emailleformulierung mit amelogenin

Info

Publication number
ATE549025T1
ATE549025T1 AT07112740T AT07112740T ATE549025T1 AT E549025 T1 ATE549025 T1 AT E549025T1 AT 07112740 T AT07112740 T AT 07112740T AT 07112740 T AT07112740 T AT 07112740T AT E549025 T1 ATE549025 T1 AT E549025T1
Authority
AT
Austria
Prior art keywords
enamel
formulation
matrix
substance
active enamel
Prior art date
Application number
AT07112740T
Other languages
English (en)
Inventor
S Lyngstadaas
Aaldert Molenberg
Original Assignee
Straumann Holding Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Straumann Holding Ag filed Critical Straumann Holding Ag
Application granted granted Critical
Publication of ATE549025T1 publication Critical patent/ATE549025T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/225—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
AT07112740T 2004-12-10 2005-12-12 Emailleformulierung mit amelogenin ATE549025T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0403014A SE0403014D0 (sv) 2004-12-10 2004-12-10 New protein formulation
US63668604P 2004-12-16 2004-12-16

Publications (1)

Publication Number Publication Date
ATE549025T1 true ATE549025T1 (de) 2012-03-15

Family

ID=33563187

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07112740T ATE549025T1 (de) 2004-12-10 2005-12-12 Emailleformulierung mit amelogenin

Country Status (6)

Country Link
US (3) US7985845B2 (de)
KR (1) KR101252978B1 (de)
AT (1) ATE549025T1 (de)
CA (1) CA2767026A1 (de)
ES (1) ES2384273T3 (de)
SE (1) SE0403014D0 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110312891A1 (en) * 2008-06-27 2011-12-22 Straumann Holding Ag Enamel matrix derivative fraction c
DK2485779T3 (en) 2009-10-07 2018-05-07 Kerecis Ehf A FRAME MATERIAL FOR SCREENING AND / OR OTHER TISSUE HEALING APPLICATIONS
EP2380920A1 (de) 2010-04-22 2011-10-26 QGel SA Hydrogelvorstufenformulierung und Herstellungsverfahren dafür
EP2566504B1 (de) 2010-10-15 2016-11-30 Straumann Holding AG Neue emd-formulierung mit pga
RU2013136826A (ru) 2011-01-07 2015-02-20 Те Юниверсити Оф Квинсленд Детекция протеолиза
US9453833B2 (en) 2011-01-07 2016-09-27 Digital Diagnostics Pty. Ltd. System and method for detecting and monitoring proteolysis of protein matrices
US9861455B2 (en) 2013-07-30 2018-01-09 TI Intellectual Property Inc. Dental implant system
US11457996B2 (en) * 2019-09-12 2022-10-04 King Abdulaziz University Dental pulp capping composition and method of preserving and regenerating capped pulp and dentin bridge
US11890154B2 (en) 2021-06-30 2024-02-06 Khalid AL HEZAIMI Pulp capping methods

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672032A (en) 1983-11-09 1987-06-09 University Of Southern California Dental enamel production
SE454480B (sv) 1986-09-25 1988-05-09 Lars Hammarstrom Bindningsinducerande komposition
SE461313B (sv) 1988-03-17 1990-02-05 Biora Ab Bindningsinducerande komposition
DK1704878T3 (da) * 1995-12-18 2013-07-01 Angiodevice Internat Gmbh Tværbundne polymerpræparater og fremgangsmåder til deres anvendelse
ATE220918T1 (de) 1998-02-27 2002-08-15 Biora Bioex Ab Matrixprotein enthaltende zusammensetzungen zur wundheilung
JP4726296B2 (ja) * 1998-02-27 2011-07-20 インスティチュート ストローマン アーゲー 創傷治癒のためのマトリックスタンパク質組成物
AU5246899A (en) 1998-07-29 2000-02-21 Northwestern University Chondrogenic and osteogenic inducing molecule
US7601685B2 (en) 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
US5997301A (en) * 1998-10-20 1999-12-07 Linden; Lars Ake Treatment of tooth surfaces and substances therefor
ES2632564T3 (es) 1999-02-01 2017-09-14 Eidgenössische Technische Hochschule Zürich Bio-materiales formados por reacción de adición nucleófila a grupos insaturados conjugados
ES2215027T3 (es) 1999-03-10 2004-10-01 Biora Bioex Ab Composiciones de proteinas de matrices destinadas a inducir la apoptosis.
MXPA02011891A (es) * 2000-06-02 2004-04-02 Eidgenoess Tech Hochschule Reacciones de adicion conjugadas para la entrega controlada de compuestos farmaceuticamente activos.
ATE445409T1 (de) 2000-06-20 2009-10-15 Straumann Inst Ag Zusammensetzungen mit matrixproteinen zur regeneration von dentin
US7033611B2 (en) * 2001-02-23 2006-04-25 Biora Bioex Ab Matrix protein compositions for guided connective tissue growth
CA2438084C (en) 2001-02-23 2011-02-15 Biora Bioex Ab Matrix protein compositions for guided connective tissue growth
CN1199336C (zh) 2001-12-14 2005-04-27 株式会社东芝 永磁式电动机和电梯装置
MXPA04006021A (es) 2001-12-18 2005-08-19 Eth Zuerich Matrices de proteina modificada con factor de crecimiento para ingenieria de tejidos.
US7247609B2 (en) * 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
WO2003080144A1 (en) 2002-03-22 2003-10-02 Kuros Biosurgery Ag Composition for hard tissue augmentation
JP4948744B2 (ja) * 2002-10-04 2012-06-06 允 深江 歯周組織再生剤、その有効成分抽出法、およびプラスミド

Also Published As

Publication number Publication date
KR20110102519A (ko) 2011-09-16
US7423013B2 (en) 2008-09-09
ES2384273T3 (es) 2012-07-03
SE0403014D0 (sv) 2004-12-10
US20090136575A1 (en) 2009-05-28
US7985845B2 (en) 2011-07-26
US20060147395A1 (en) 2006-07-06
US8029769B2 (en) 2011-10-04
CA2767026A1 (en) 2006-06-22
KR101252978B1 (ko) 2013-04-15
US20090060999A1 (en) 2009-03-05

Similar Documents

Publication Publication Date Title
ATE549025T1 (de) Emailleformulierung mit amelogenin
BRPI0507812A (pt) sistema de microativação, método para a microativação das células epidérmicas, kit, método para montar o dispositivo de microativação e método para a microativação da pele
BRPI0617077A2 (pt) Agente terapêutico para tratamento de doenças do fígado contendo 2-amina-1, 3-propanediol derivativo como ingrediente ativo, e método para tratamento de doenças do fígado
BRPI0923589A2 (pt) uso de uma composição espumável essencialmente livre de ingredientes farmaceuticamente ativos para o tratamento da pele humana.
AR049518A1 (es) Composicion farmaceutica que comprende un agente siliconado y dos principios activos solubilizados
BRPI0518869A2 (pt) agentes citotàxicos compreendendo taxanos
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
WO2011049958A3 (en) Modulation of gel temperature of poloxamer-containing formulations
AR063446A1 (es) Sistema de administracion para el tratamiento remoto de un animal
CR11723A (es) Agente para tratar enfermedad
ATE482726T1 (de) Neuartiges mittel zur freisetzung von wirkstoffen in dressings mit mindestens einer fettigen substanz
WO2006064381A3 (en) Protein formulation
MX2012009490A (es) Composicion en gel posespumante que comprende un agente contra la irritacion.
BRPI0318278B8 (pt) Compostos de éter aminocicloexílico, composição compreendendo ditos compostos, usos dos mesmos e método para modular a atividade do canal iônico em um ambiente in vitro
DE602007004093D1 (de) 3-substituierte n-(aryl- oder heteroaryl)pyrazoä1,5-aüpyrimidine als kinaseinhibitoren
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica
CR11259A (es) Bromhidrato de bupropion y aplicaciones terapueticas
AR051664A1 (es) Agente contra la demodicosis
TW200635616A (en) Organic compounds
WO2005094265A3 (en) Self assembling activation agents targeted using active drug release
CL2008000495A1 (es) Compuestos derivados de tetrahidro-pirazolo[4,3-c]piridina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como alergias, inflamacion, dolor, cancer, entreotras.
GT200400220A (es) Productos para las axilas con componente superabsorbente.
DE602008003199D1 (de) Glucoseisomerase zur behandlung von fructose-unverträglichkeit
EA200800722A1 (ru) Средство, активирующее стволовые клетки и/или клетки-предшественники
ITMI20050013A1 (it) Agente deodorante che contiene una cellula secca di un microorganismo come ingrediente attivo e metodo deodorante